These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36232129)

  • 41. Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system.
    Pedersen SS; Carter N; Barr C; Scholten M; Lambiase PD; Boersma L; Johansen JB; Theuns DAMJ;
    Pacing Clin Electrophysiol; 2019 Dec; 42(12):1541-1551. PubMed ID: 31677279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients.
    Dunbar SB; Langberg JJ; Reilly CM; Viswanathan B; McCarty F; Culler SD; O'Brien MC; Weintraub WS
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1259-71. PubMed ID: 19796343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
    Hoogwegt MT; Kupper N; Jordaens L; Pedersen SS; Theuns DA
    Europace; 2013 Oct; 15(10):1468-74. PubMed ID: 23608028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial.
    Versteeg H; Timmermans I; Widdershoven J; Kimman GJ; Prevot S; Rauwolf T; Scholten MF; Zitron E; Mabo P; Denollet J; Pedersen SS; Meine M
    Europace; 2019 Sep; 21(9):1360-1368. PubMed ID: 31168604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.
    Rahmawati A; Chishaki A; Ohkusa T; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H
    J Arrhythm; 2016 Apr; 32(2):102-7. PubMed ID: 27092190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-Reported Outcomes in a Multidisciplinary Electrophysiology-Psychology Ventricular Arrhythmia Clinic.
    Sandhu U; Nguyen AT; Dornblaser J; Gray A; Paladino K; Henrikson CA; Kovacs AH; Nazer B
    J Am Heart Assoc; 2022 Aug; 11(15):e025301. PubMed ID: 35904213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study).
    Frydensberg VS; Johansen JB; Möller S; Riahi S; Wehberg S; Haarbo J; Philbert BT; Jørgensen OD; Larsen ML; Nielsen JC; Pedersen SS
    Europace; 2020 Dec; 22(12):1830-1840. PubMed ID: 33106878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
    Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
    J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot.
    Opić P; Utens EM; Moons P; Theuns DA; van Dijk AP; Hoendermis ES; Vliegen HW; de Groot NM; Witsenburg M; Schalij M; Roos-Hesselink JW
    Clin Res Cardiol; 2012 Jul; 101(7):509-19. PubMed ID: 22314278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial.
    Zhang S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Lexcen DR; Muckala K; Brown ML; Cheng A; Singh B;
    Heart Rhythm; 2020 Mar; 17(3):468-475. PubMed ID: 31561030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery.
    Hallas CN; Burke JL; White DG; Connelly DT
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):170-7. PubMed ID: 20197542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
    Luyster FS; Hughes JW; Waechter D; Josephson R
    Psychosom Med; 2006; 68(5):794-800. PubMed ID: 17012535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation.
    Isaksen K; Morken IM; Munk PS; Larsen AI
    Eur J Prev Cardiol; 2012 Aug; 19(4):804-12. PubMed ID: 22988593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anxiety predicts mortality in ICD patients: results from the cross-sectional national CopenHeartICD survey with register follow-up.
    Kikkenborg Berg S; Caspar Thygesen L; Hastrup Svendsen J; Vinggaard Christensen A; Zwisler AD
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1641-50. PubMed ID: 25196176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The INFluence of Remote monitoring on Anxiety/depRession, quality of lifE, and Device acceptance in ICD patients: a prospective, randomized, controlled, single-center trial.
    Leppert F; Siebermair J; Wesemann U; Martens E; Sattler SM; Scholz S; Veith S; Greiner W; Rassaf T; Kääb S; Wakili R
    Clin Res Cardiol; 2021 Jun; 110(6):789-800. PubMed ID: 32417952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients.
    Lee JH; Yu HT; Oh IY; Choi EK; Sung JH; Lee YS; Kim JY; Baek Y; Park J; Joung B;
    Yonsei Med J; 2020 Nov; 61(11):942-950. PubMed ID: 33107237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: identification of foci for nursing intervention.
    Wong FM; Sit JW; Wong EM; Choi KC
    J Adv Nurs; 2014 Dec; 70(12):2821-34. PubMed ID: 24754723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator.
    Wong MF
    J Clin Nurs; 2017 May; 26(9-10):1328-1337. PubMed ID: 27859926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.